نتائج البحث

Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors

• Authors : National Cancer Institute (NCI)

• Source: Phase I-II Study of Ruxolitinib (INCB18424) for Patients With Chronic Myeloid Leukemia (CML) With Minimal Residual

تفاصيل العنوان

Low dimensional representation of multi-patient flow cytometry datasets using optimal transport for minimal residual disease detection in leukemia

• Authors : Gachon, Erell; Bigot, Jérémie; Cazelles, Elsa

Subjects: Statistics - Machine Learning; Computer Science - Machine Learning; Mathematics - Statistics Theory

تفاصيل العنوان

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma

• Authors : Nahi, H; Afram, G; Uttervall, K

Subjects: Medicin och hälsovetenskap

• Source: Cancer medicine. 12(22):20736-20744

تفاصيل العنوان

A Perspective, Single Center Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment (MRD)

• Authors : FengYan Jin, Clinical Professor of Hematology Department

• Source: Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC. Multiple myeloma. Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46.Anderson KC. Progress

تفاصيل العنوان

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

• Authors : Bellicum Pharmaceuticals, Inc.

• Source: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With

تفاصيل العنوان

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.

• Authors : Parikh, Aparna; Chee, Bryant; Tsai, Jill

Subjects: Humans; Colorectal Neoplasms; Circulating Tumor DNA

• Source: Clinical Cancer Research. 30(14)

تفاصيل العنوان

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

• Authors : National Cancer Institute (NCI)

• Source: Phase II Study of Blinatumomab in Patients With B-Cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual

تفاصيل العنوان

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

• Authors : National Cancer Institute (NCI)

• Source: Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal

تفاصيل العنوان

The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.

• Authors : Verbeek, Martijn W. C.¹ (AUTHOR); van der Velden, Vincent H. J.¹ (AUTHOR)

Subjects: *LYMPHOBLASTIC leukemia; *ACUTE leukemia; *B cells

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4881. 19p.

تفاصيل العنوان

Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma

• Authors : Hultcrantz, M; Rustad, EH; Yellapantula, V

Subjects: Medicin och hälsovetenskap

• Source: Clinical cancer research : an official journal of the American Association for Cancer Research. 28(10):2160-2166

تفاصيل العنوان